{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:03:59Z","timestamp":1788444239112,"version":"build-2803163510"},"reference-count":114,"publisher":"Informa UK Limited","issue":"24","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.4155\/bio-2017-0175","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T11:36:47Z","timestamp":1512473807000},"page":"1997-2014","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Ocular Bioanalysis: Challenges and Advancements in Recent Years for These Rare Matrices"],"prefix":"10.1080","volume":"9","author":[{"given":"Katja","family":"Heinig","sequence":"first","affiliation":[{"name":"Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Bertran","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Potter","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fraier","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"World Health Organization . www.who.int\/mediacentre\/factsheets\/fs282\/en\/."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2014-0221"},{"key":"e_1_3_3_4_1","volume-title":"11th Workshop on Recent Issues in Bioanalysis","author":"Fraier D","year":"2017","unstructured":"Fraier D . Drugs in Ocular Fluids\/Tissue: why so many challenges in method development & validation? What are the current solutions?Presented at : 11th Workshop on Recent Issues in Bioanalysis. LA, USA, 3\u20137 April 2017."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-016-0188-2"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-29346-2_26"},{"key":"e_1_3_3_7_1","unstructured":"Glaucoma Research Foundation . www.glaucoma.org."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.12.029"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-2247(14)50021-4"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.01.007"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2017-0018"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1227785"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.01.012"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2016.1218460"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717544.2016.1172368"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.01.007"},{"issue":"160","key":"e_1_3_3_17_1","first-page":"1","article-title":"The effects of oral and topical corticosteroid in rabbit corneas","volume":"16","author":"Araki-Sasaki K","year":"2016","unstructured":"Araki-Sasaki K , KatsutaO, ManoH, NaganoT, NakamuraM. The effects of oral and topical corticosteroid in rabbit corneas. BMC Ophthalmology16 (160), 1\u20136 (2016).","journal-title":"BMC Ophthalmology"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2017.1324531"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.04.057"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.03.005"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S118409"},{"key":"e_1_3_3_22_1","volume-title":"Ocular Pharmacology and Toxicology. Methods in Pharmacology and Toxicology","author":"Velagaleti PR","year":"2014","unstructured":"Velagaleti PR , BuonaratiMH. Challenges and strategies in drug residue measurement (bioanalysis) of ocular tissues. In : Ocular Pharmacology and Toxicology. Methods in Pharmacology and Toxicology. GilgerB (Ed). Humana Press, Totowa, NJ (2014)."},{"key":"e_1_3_3_23_1","volume-title":"Eliminating Bottlenecks for Efficient Bioanalysis: Practices and Applications in Drug Discovery and Development","author":"Ho S","year":"2014","unstructured":"Ho S . Tissue analysis and tissue imaging. In : Eliminating Bottlenecks for Efficient Bioanalysis: Practices and Applications in Drug Discovery and Development. ShouWZ, WengN (Eds). Future Science Group, London, UK (2014)."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.336"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.252"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.230"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.12.19"},{"key":"e_1_3_3_28_1","volume-title":"Tissue Analysis for Drug Development","author":"Tsefrikas V","year":"2013","unstructured":"Tsefrikas V , ZhangX. Analysis of small molecule drugs in tissue: current practices. In : Tissue Analysis for Drug Development. HoS (Ed.). Future Science Group, London, UK (2013)."},{"key":"e_1_3_3_29_1","volume-title":"9th European Bioanalysis Forum Open Meeting","author":"Bertran E","year":"2016","unstructured":"Bertran E . Challenges in ocular bioanalysis. Presented at : 9th European Bioanalysis Forum Open Meeting. Barcelona, Spain, 16\u201318 November 2016."},{"key":"e_1_3_3_30_1","volume-title":"9th European Bioanalysis Forum Open Meeting","author":"Hantash J","year":"2016","unstructured":"Hantash J . Method Development and Validation of Biologics and Small Molecules in Ocular Tissues \u2013 Focusing on Bioanalytical Challenges and Foreseeing Regulatory Concerns. Presented at : 9th European Bioanalysis Forum Open Meeting, Barcelona, Spain, 6\u201318 November 2016."},{"key":"e_1_3_3_31_1","volume-title":"8th European Bioanalysis Forum Open Meeting","author":"Heinig K","year":"2015","unstructured":"Heinig K , DzygielP, BucheliFet al. Challenges in ocular bioanalysis. 8th European Bioanalysis Forum Open Meeting, Barcelona, Spain, 18\u201320 November 2015."},{"key":"e_1_3_3_32_1","volume-title":"The Land O\u2019Lakes Bioanalytical Conference","author":"Tsefrikas V","year":"2012","unstructured":"Tsefrikas V , BennettD, GoodsellKet al. Analysis of ocular tissues: investigation of potential matrix effects. Presented at : The Land O\u2019Lakes Bioanalytical Conference. Merrimac, WI, USA, 15\u201318 July 2012."},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2013.0142"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.03.025"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-015-0389-x"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2015.0003"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S91286"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4052094"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0097"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0164"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2016.09.006"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3740"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2014.01.031"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.05.030"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-014-0218-5"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8574-9"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2016.0069"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2014.0140"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2012.09.014"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.01.015"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2014.0047"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2017.04.040"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.08.023"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0319-4"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.4.3.1"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19585"},{"key":"e_1_3_3_57_1","doi-asserted-by":"crossref","first-page":"e000063","DOI":"10.1136\/bmjophth-2016-000063","article-title":"Oral administration of the 11bhydroxysteroid- dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study","volume":"1","author":"Schwab D","year":"2017","unstructured":"Schwab D , SturmC, PortronAet al. Oral administration of the 11bhydroxysteroid- dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study. BMJ Open Ophthalmol. 1, e000063 (2017).","journal-title":"BMJ Open Ophthalmol"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2016.0195"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2016.02.014"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.10.009"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2014.0100"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0308-9"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387815-1.00013-7"},{"issue":"253","key":"e_1_3_3_64_1","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1111\/j.1755-3768.2014.S005.x","article-title":"Comparison of ocular tissue weights (volumes) and tissue collection techniques in commonly used preclinical animal species","volume":"92","author":"Struble C","year":"2014","unstructured":"Struble C , HowardS, RelphJ. Comparison of ocular tissue weights (volumes) and tissue collection techniques in commonly used preclinical animal species. Acta Ophthalmol. 92 (s253), 0 (2014).","journal-title":"Acta Ophthalmol"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0339-2"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2010.05.009"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.12.037"},{"key":"e_1_3_3_68_1","volume-title":"Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics","author":"Capiau S","year":"2016","unstructured":"Capiau S , AlffenaarJW, StoveCP. Alternative sampling strategies for therapeutic drug monitoring. In : Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics. ClarkeW, DasguptaA (Eds). Elsevier, Amsterdam, The Netherlands (2016)."},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.4172\/jbb.10000e73"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.2996"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2012.10.001"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.201"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.39"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.317"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.290"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-54802-9"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118671276"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.13.29"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0040"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9573-z"},{"key":"e_1_3_3_81_1","volume-title":"Targeted Biomarker Quantitation by LC\u2013MS","author":"Tan A","year":"2017","unstructured":"Tan A , FanarasJC. Nonspecific binding in LC\u2013MS bioanalysis. In:WengN, JianW (Eds). Targeted Biomarker Quantitation by LC\u2013MS. John Wiley & Sons, NJ, USA (2017)."},{"issue":"2","key":"e_1_3_3_82_1","first-page":"46","article-title":"Matrix effects: Hurdle for development and validation of bioanalytical LC\u2013MS methods in biological samples analyses","volume":"4","author":"Kim H-J","year":"2016","unstructured":"Kim H-J , KangJ-S. Matrix effects: Hurdle for development and validation of bioanalytical LC\u2013MS methods in biological samples analyses. Biodesign4 (2), 46\u201358 (2016).","journal-title":"Biodesign"},{"key":"e_1_3_3_83_1","first-page":"1","article-title":"Hazards in chromatographic bioanalysis method development and applications","volume":"31","author":"Bartlett MG","year":"2017","unstructured":"Bartlett MG , HooshfarS. Hazards in chromatographic bioanalysis method development and applications. Biomed. Chromatogr. 31, 1\u201310 (2017).","journal-title":"Biomed. Chromatogr"},{"issue":"2","key":"e_1_3_3_84_1","first-page":"198","article-title":"Pioneering better science through the 3Rs: an introduction to the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs)","volume":"54","author":"Burden N","year":"2015","unstructured":"Burden N , ChapmanK, SewellF, RobinsonV. Pioneering better science through the 3Rs: an introduction to the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs). J. Am. Assoc. Lab. Anim. Sci. 54 (2), 198\u2013208 (2015).","journal-title":"J. Am. Assoc. Lab. Anim. Sci"},{"key":"e_1_3_3_85_1","volume-title":"The Animal Ethics Reader","author":"Festing S","year":"2016","unstructured":"Festing S , WilkinsonR. The ethics of animal research. In : The Animal Ethics Reader. ArmstrongSJ, BotzlerRG (Eds). Taylor & Francis, London, UK (2016)."},{"issue":"2","key":"e_1_3_3_86_1","first-page":"192","article-title":"Making progress and gaining momentum in global 3Rs efforts: how the European Pharmaceutical Industry is contributing","volume":"54","author":"Gill Fleetwood","year":"2015","unstructured":"Gill Fleetwood , MagdaChlebus, JoachimCoenenet al. Making progress and gaining momentum in global 3Rs efforts: how the European Pharmaceutical Industry is contributing. J. Am. Assoc. Lab. Anim. Sci. 54 (2), 192\u2013197 (2015).","journal-title":"J. Am. Assoc. Lab. Anim. Sci"},{"key":"e_1_3_3_87_1","volume-title":"Comparative Medicine","author":"Waxenecker G","year":"2017","unstructured":"Waxenecker G , BinderR. Regulatory animal testing for the development of medicines. In : Comparative Medicine. Jensen-JarolimE (Eds). Springer, Cham (2017)."},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.161"},{"issue":"1","key":"e_1_3_3_89_1","first-page":"47","article-title":"An artificial aqueous humor as a standard matrix to assess drug concentration in the anterior chamber by high performance liquid chromatography methods","volume":"61","author":"Macri A","year":"2015","unstructured":"Macri A , MariniV, SangalliG, FucileC, IesterM, MattioliF. An artificial aqueous humor as a standard matrix to assess drug concentration in the anterior chamber by high performance liquid chromatography methods. Clin. Lab. 61 (1\u20132), 47\u201352 (2015).","journal-title":"Clin. Lab"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.168"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24680"},{"key":"e_1_3_3_92_1","volume-title":"Handbook of Experimental Pharmacology","author":"Durairaj C","year":"2016","unstructured":"Durairaj C . Ocular pharmacokinetics in pharmacologic therapy of ocular disease. In : Handbook of Experimental Pharmacology. WhitcupS, AzarD (Eds). Springer, Heidelberg, Germany (2016)."},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23557"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.05.003"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.03.008"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22764"},{"issue":"174","key":"e_1_3_3_97_1","first-page":"1","article-title":"Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research","volume":"5","author":"Tuntland T","year":"2014","unstructured":"Tuntland T , EthellB, KosakaTet al. Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Front. Pharmacol. 5 (174), 1\u201316 (2014).","journal-title":"Front. Pharmacol"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0280-7"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.02.012"},{"key":"e_1_3_3_100_1","volume-title":"Guidance for Industry Bioanalytical Method Validation","year":"2001","unstructured":"Guidance for Industry Bioanalytical Method Validation . US Department of Health and Human Services, US FDA, MD, USA (2001). www.fda.gov\/downloads\/Drugs\/Guidance\/ucm070107.pdf."},{"key":"e_1_3_3_101_1","volume-title":"Guideline on Bioanalytical Method Validation","year":"2011","unstructured":"Guideline on Bioanalytical Method Validation . European Medicines Agency, London, UK (2011). www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdf."},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.34"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.16"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.14.14"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781119413073"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0040"},{"key":"e_1_3_3_107_1","volume-title":"9th European Bioanalysis Forum Open Meeting","author":"Timmermann P","year":"2016","unstructured":"Timmermann P . What does GLP mean in regulated Bioanalysis or Biomarker Bioanalysis. Presented at : 9th European Bioanalysis Forum Open Meeting. Barcelona, Spain, 16\u201319 November 2016."},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.5021"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1177\/2472555217724780"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0158"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/05704928.2016.1207659"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2017-0122"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1089\/biores.2016.0008"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0330-y"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.09.052"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio-2017-0175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:02:35Z","timestamp":1715961755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio-2017-0175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":114,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.4155\/bio-2017-0175"],"URL":"https:\/\/doi.org\/10.4155\/bio-2017-0175","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-10-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}